CPSC Announces Recall of Triaminic® and Theraflu Warming Relief® Cough Syrups
Feb. 4, 2013
The Consumer Product Safety Commission (CPSC) has announced that over-the-counter drug manufacturer, Novartis, in conducting a voluntary recall of both Triaminic® and Theraflu Warming Relief® Syrups. A press release from the agency explained the recall was being conducted due to a problem with the childproof caps on the bottles containing the cough syrup.
Both syrups contain ingredients such as acetaminophen and diphenhydramine, which are meant to reduce fevers. Ingesting too much of these medications can result in a drug injury known as acute liver dysfunction or failure, which can result in death if left untreated. The law requires products containing these drugs be packaged in childproof containers. However, there have been several recent reports of children removing the tamperproof lid off of the bottles of Triaminic® and Theraflu Warming Relief® Syrup and ingesting more than the recommended dosage allows. In one of these cases, a child required medical treatment.
A total of 2.3 million units are affected by the recall, and anyone in possession of the Defective Product should halt its use immediately. They should then contact Novartis to learn how to properly dispose of the medication and get a replacement or refund.
The Denver Personal Injury Lawyers with McDivitt Law Firm are hopeful the recall will prevent further cases of tamperproof lid failures resulting in harm to a person.Back to the Blog